RT Journal Article
SR Electronic
T1 Blood bacterial DNA, intestinal adenoma and colorectal cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.22.21260498
DO 10.1101/2021.07.22.21260498
A1 Mutignani, Massimiliano
A1 Penagini, Roberto
A1 Gargari, Giorgio
A1 Guglielmetti, Simone
A1 Cintolo, Marcello
A1 Airoldi, Aldo
A1 Leone, Pierfrancesco
A1 Carnevali, Pietro
A1 Ciafardini, Clorinda
A1 Petrocelli, Giulio
A1 Mascaretti, Federica
A1 Oreggia, Barbara
A1 Dioscoridi, Lorenzo
A1 Cavalcoli, Federica
A1 Primignani, Massimo
A1 Pugliese, Francesco
A1 Bertuccio, Paola
A1 Soru, Pietro
A1 Magistro, Carmelo
A1 Ferrari, Giovanni
A1 Speciani, Michela
A1 Bonato, Giulia
A1 Bini, Marta
A1 Cantù, Paolo
A1 Caprioli, Flavio
A1 Vangeli, Marcello
A1 Forti, Edoardo
A1 Mazza, Stefano
A1 Tosetti, Giulia
A1 Bonzi, Rossella
A1 Vecchi, Maurizio
A1 Vecchia, Carlo La
A1 Rossi, Marta
YR 2021
UL http://medrxiv.org/content/early/2021/07/24/2021.07.22.21260498.abstract
AB Objective We aimed to investigate the relation of blood bacterial DNA load and profiling with intestinal adenoma (IA) and colorectal cancer (CRC) patients.Design We performed 16S rRNA gene analysis of blood from 100 incident histologically confirmed CRC cases, 100 IA and 100 healthy subjects, matched to cases by centre, sex and age. Bacterial load was analysed using multiple conditional logistic regression. Differences in terms of abundance of bacteria between groups were estimated through analysis based on negative binomial distribution normalization. Random Forest was applied to predict the group assignment.Results We found an overrepresentation of blood 16S rRNA gene copies in colon cancer as compared to tumor-free controls (IA and healthy subjects). The odds ratio of colon cancer for the highest versus the lowest three quintiles of gene copies was 2.62. (95% confidence interval=1.22-5.65). No difference was found for rectal cancer and IA. For high 16S rRNA, community diversity was higher in colon cancers than controls. CRC cases had an enrichment of Peptostreptococcaceae and Acetobacteriaceae and a reduced abundance of Bacteroidaceae, Lachnospiraceae, and Ruminococcaceae. Identified variables predicted CRC from control and IA patients with an accuracy of 0.70.Conclusion Colon cancer patients had a higher DNA bacterial load and a different bacterial profiling as compared to healthy subjects, IA and rectal cancers, indicating a higher passage of bacteria from gastrointestinal tract to bloodstream. Further studies are needed to confirm this result and exploit it to conceive new non-invasive techniques for an early diagnosis of CRC.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Italian Foundation for Cancer Research (AIRC) (My First AIRC grant no. 17070).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was revised and approved by the ethical committees of the hospitals involved in data recruitment: Azienda Socio Sanitaria Territoriale (ASST) Grande Ospedale Metropolitano Niguarda (No. 477-112016) and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico (No. 742-2017), Milan, Italy.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe epidemiological data that support the findings of this study are available upon reasonable request from the corresponding author (MR). Raw metagenomic reads are publicly available in the European Nucleotide Archive (ENA) with the accession number: PRJEB46474.